Orange Book product · Generic (ANDA)
BACITRACIN
BACITRACIN
At a glance
Jul 27, 1983
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 27, 1983
43 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
BACITRACIN
Strength
5,000,000 UNITS/BOT
Dosage form
POWDER
Route
FOR RX COMPOUNDING
TE code
Not listed
Application
ANDA 062456
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BACITRACIN
- 1987BACITRACINGeneric (ANDA)
ANDA 062857 · NASKA
- 1987BACITRACINGeneric (ANDA)
ANDA 062799 · COMBE
- 1984BACITRACINGeneric (ANDA)
ANDA 062453 · PHARMAFAIR
- —BACIGUENTGeneric (ANDA)
ANDA 060734 · PHARMACIA AND UPJOHN
- —BACITRACINGeneric (ANDA)
ANDA 060687 · LILLY
- —BACITRACINGeneric (ANDA)
ANDA 061212 · PADAGIS US
- —BACITRACINGeneric (ANDA)
ANDA 062158 · PHARMADERM
- —BACI-RXGeneric (ANDA)
ANDA 061580 · X GEN PHARMS
- —BACITRACINGeneric (ANDA)
ANDA 061699 · APOTHEKERNES
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
